Skip to content

Acupressure in Hyperemesis Gravidarum

A Randomised Controlled Trial On Effect Of Acupressure On Nausea And Vomiting In Women With Hyperemesis Gravidarum

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05175079
Enrollment
90
Registered
2022-01-03
Start date
2016-10-01
Completion date
2017-08-31
Last updated
2022-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperemesis Gravidarum

Brief summary

To examine the degree of nausea, vomiting between the acupressure and control group in women with hyperemesis gravidarum

Detailed description

A prospective RCT conducted at Department of Obst and Gynae, UKMMC. All pregnant women with a normal intrauterine pregnancy of ≤ 16 week gestation with hyperemesis gravidarum will be assessed by the medical officer/ specialist/ consultant in charge. Explanation regarding the research study will be given for patients who fulfill the inclusion and exclusion criteria. Patients who have understood the research study and consented will be recruited as subjects for the study.

Interventions

acupressure band apply to P6 (nei guan) point which located three fingers below the skin wrinkles of the anterior wrist. Acupressure band wear 3 times daily before breakfast, lunch and dinner for at least 10 minutes

OTHERStandard treatment hospital protocol

Intravenous metaclopromide 10mg PRN Intravenous fluids as per protocol

Sponsors

Universiti Kebangsaan Malaysia Medical Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Onset of vomiting before 16 weeks 2. Vomiting at least 2 times per day 3. Ketonuria on admission 4. Mid stream urine specimen that did not indicate infection

Exclusion criteria

1. Non viable pregnancy 2. Molar pregnancy 3. Overt clinical features of thyrotoxicosis 4. Known case of medical illness that associated with nausea and vomiting 5. Patient refusal or patients who are not able to give consent

Design outcomes

Primary

MeasureTime frameDescription
Degree of nausea and vomitingday 1 to day 3measure the effect of acupressure using modified Pregnancy Unique Quantification of Emesis and Nausea (PUQE)

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026